おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Tyercan
company
About
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
Highlights
Details
- Last Funding Type
- Angel
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical,Product Research
- Founded date
- Jan 1, 2017
- Operating Status
- Active
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Tyercan has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2021 from a Angel round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2021 | Angel | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Tyercan is funded by 1 investors.
BIOCHING CAPITAL
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
BIOCHING CAPITAL
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
